Pediatrix Medical Group Reports Third Quarter Results

Go back to Pediatrix Medical Group Reports Third Quarter Results

MEDNAX (MD) Tops Q3 EPS by 7c, Beats on Revenue; Reaffirms EBITDA Guidance

October 29, 2026 6:05 AM EDT

MEDNAX (NYSE: MD) reported Q3 EPS of $0.72, $0.07 better than the analyst estimate of $0.65. Revenue for the quarter came in at $501 million versus the consensus estimate of $498.19 million.

Pediatrix anticipates that its full year 2026 outlook for Adjusted EBITDA, as defined above, will be... More